Multidisciplinary study finds estrogen could aid in therapies for progressive multiple sclerosis
About 100,000 of the estimated million people in the United States with multiple sclerosis (MS) have a progressive form of the disease, with symptoms that worsen continuously or after periods of remission.
“Progressive MS is profoundly challenging because it is relentless and treatment options are limited,” said Francisco P. Gomez, a neurologist who specializes in MS and neuroimmunology.
MS is believed to occur when the immune system attacks the myelin sheath — the protective coating of the nerve fibers that transmit ...